Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-01-15

Clinical Trial Update: Cardiology Prevention in Systemic Lupus Erythematosus (SLE) [NA]

View source ↗

Summary

The University of Pittsburgh-sponsored clinical trial on cardiology prevention in systemic lupus erythematosus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Systemic Lupus Erythematosus | NA | Status: WITHDRAWN